Georgia Regents University widened its already broad cancer focus Friday when it hosted the Society for Immunotherapy of Cancer CME- and CNE-certified regional program “Advances in Cancer Immunotherapy – Augusta, Georgia.”
Organized by Dr. Esteban Celis, GRU professor of Biochemistry and Molecular Biology, Dr. Samir N. Khleif, director of the GRU Cancer Center, and Dr. Zihai Li, chair of the department of Microbiology & Immunology at the Medical University of South Carolina, the one-day conference was part of a series of “Advances in Cancer Immunotherapy” regional programs presented by leading cancer authorities across the country.
Designed specifically for members of the traditional cancer immunotherapy treatment team, these programs provide an understanding of basic immunology principles in the clinical application and management of cancer immunotherapy.
During presentations, emerging drugs and concepts in the cancer immunotherapy field are also typically discussed.
The event continues until 4 p.m. in the Health Sciences Building, Room 1204. A list of panels can be found here.
In hosting this event, the GRU Cancer Center has once again propelled Augusta into the ranks of other prestigious cancer research destinations across the United States, sharing the spotlight with cities such as Chicago, Los Angeles and Princeton, New Jersey.
Earlier this month, The GRU Cancer Center made another big splash when The Community Foundation for the CSRA donor-advised fund Press On donated $2.5 million to fund pediatric cancer research and treatment at GRU. To read more about that donation, click here.